SCHEMBL16905640

SCHEMBL16905640

CC(=O)N[C@@H](CCCNC(=N)N)C(=O)OCCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.39
▸ SIRT1 Q96EB6 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ NPY4R P50391 8/20 0.36
▸ NPY1R P25929 5/20 0.36
▸ SIRT5 Q9NXA8 2/20 0.36
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ ALB P02768 1/20 0.34
▸ NPY2R P49146 3/20 0.33
▸ NPY5R Q15761 3/20 0.33
▸ TLR2 O60603 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ FOLH1 Q04609 1/20 0.32
▸ GNPAT O15228 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5807639 0.89 SIRT6 (0.44) SIRT6SIRT1ACHENPY4RNPY1R
SCHEMBL5807641 0.89 SIRT6 (0.44) SIRT6SIRT1ACHENPY4RNPY1R
SCHEMBL5812133 0.86 SIRT6 (0.43) SIRT6SIRT1NPY4RNPY1RSIRT5
SCHEMBL5812127 0.86 SIRT6 (0.43) SIRT6SIRT1NPY4RNPY1RSIRT5
SCHEMBL2390736 0.86 NPY4R (0.44) SIRT6SIRT1NPY4RNPY1RSIRT5
SCHEMBL5807981 0.86 NPY4R (0.44) SIRT6SIRT1NPY4RNPY1RSIRT5
Hydrochloric Acid SCHEMBL11506342 0.85 NPY4R (0.44) SIRT6SIRT1NPY4RNPY1RSIRT5
SCHEMBL28406173 0.83 SIRT6 (0.40) SIRT6SIRT1NPY4RNPY1RSIRT5
SCHEMBL5814337 0.82 SIRT6 (0.39) SIRT6SIRT1NPY4RNPY1RSIRT5
SCHEMBL5814333 0.82 SIRT6 (0.39) SIRT6SIRT1NPY4RNPY1RSIRT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150197500-A1 NO-RELEASING GUANIDINE-CHROMENE CONJUGATES EUCLISES PHARMACEUTICALS INC (US) 2015-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197500-A1 NO-RELEASING GUANIDINE-CHROMENE CONJUGATES ARG1, ARGLU1, CGAS SIRT6 1608/4885SIRT1 984/4885ACHE 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback